Reflections from news and commentary of the day
Subscribe To
Posts
Comments
Thursday, October 21, 2021
New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19 - ScienceDirect
New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19 - ScienceDirect: We report on nine patients (eight cases of MS and one case of NMOSD) who presented a disease relapse in close temporal association with their first AZ…
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment